Moleculin Biotech (MBRX) just unveiled an update.
Moleculin Biotech, Inc. has released a new corporate presentation on its website, designed to provide current and potential investors with insights into the company’s developments and strategic direction. While this information represents an update, it is furnished for informational purposes and not for regulatory filing or formal endorsement under key securities legislation.
For detailed information about MBRX stock, go to TipRanks’ Stock Analysis page.
